Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Cardiovascular risk score predicts multiple eye diseases

Written by | 11 Jan 2026

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later…. read more.

Long-term efficacy and safety of Eylea 8 mg (aflibercept 8 mg) with extended dosing intervals in wet age-related macular degeneration confirmed at three years – Bayer

Written by | 29 Jul 2025

Bayer and its collaboration partner Regeneron presented results from the open-label extension study of the clinical trial PULSAR in patients with neovascular (wet) age-related macular degeneration (nAMD) at… read more.

Eylea (aflibercept) 8 mg approved in China for wet age-related macular degeneration – Bayer

Written by | 9 Jul 2025

The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved Eylea 8 mg (aflibercept 8 mg) for the treatment of neovascular (wet) age-related… read more.

Euroopean Commission approves Vabysm (faricimab) pre-filled syringe for neovascular or ‘wet’ age-related macular degeneration, diabetic macular edema and macular edema following RVO – Roche

Written by | 18 Jan 2025

Roche announced that the European Medicines Agency has approved Vabysmo  (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related macular… read more.

New strategy for eye condition could replace injections with eyedrops

Written by | 6 Oct 2023

A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition… read more.

UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases

Written by | 10 May 2023

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and… read more.

Blinding eye disease is strongly associated with heart disease and stroke

Written by | 14 Jul 2022

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke,… read more.

Trigger found for harmful inflammation in lupus, macular degeneration

Written by | 16 Dec 2021

Researchers at the University of Virginia School of Medicine have made a discovery linking lupus, a potentially debilitating autoimmune disorder, and macular degeneration, a leading cause of blindness…. read more.

Eye conditions linked to heightened risk of dementia

Written by | 20 Sep 2021

Risk of dementia increases with age-related macular degeneration, cataract and diabetes-related eye disease, but not glaucoma. Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.